Obesity Medicine 2024 - Continuous Glucose Monitoring in Obesity Care (Recorded)

Obesity Medicine 2024 - Continuous Glucose Monitoring in Obesity Care (Recorded)

Obesity medicine clinicians routinely care for patients with diabetes and treatment often results in significant changes in blood glucose and is associated with a high risk for hypoglycemia. Continuous glucose monitoring (CGM) is a tool recommended for use in patients with diabetes and has demonstrated improved glucose control and reduced episodes of hypoglycemia. For this reason, the obesity medicine clinician should be familiar with when and how to use this technology in clinical practice. This presentation will review CGM technology, clinical guidelines recommending CGM use, interpretation of CGM readings, and a general overview of revenue associated with CGM use in the clinic. The presentation will also include real-life clinical examples of how CGM is used in an obesity treatment clinic. CME/CE Expiration Date: 4/26/27 *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

  • Provider:Obesity Medicine Association
  • Activity Link: https://academy.obesitymedicine.org/node/6140
  • Start Date: 2024-04-29 05:00:00
  • End Date: 2024-04-29 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
  • Commercial Support: No
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: Variable
  • Measured Outcome: Learner Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.